Status: UPDATED
| Advisory ID: CVE-2026-21997
Key Details
| CVE | CVE-2026-21997 |
| CVSS Score / Version | 8.5 (High) / CVSS v3.1 |
| Updated | 2026-09-24 |
| CVSS Vector | CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N |
| CVSS Prose | attack vector is network; attack complexity is low; privileges required is low; user interaction is none; scope is changed; confidentiality impact is low; integrity impact is high; availability impact is none. |
| Affected products | Oracle Life Sciences Empirica Signal |
| Classified as | CWE-284 (Improper Access Control) |
| Exploitation prediction (EPSS) | 0.20% probability of exploitation in the next 30 days (9% percentile) -- FIRST.org's EPSS model. |
Affected Products, Subsystems & Sectors
| Subsystems | General OT |
| Sectors | Multiple |
What to Know
Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core). Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N).
What to Do
Monitor Oracle's web page for any future patch releases. See vendor advisory link below.
References